Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies

(Paris:ABVX),(NasdaqGM:ABVX), Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies 50 mg dose of once-daily obefazimod achieved clinically meaningful improvements, across all endpoints, regardless of prior inadequate response to advanced therapies (AT-IR) 50mg dose demonstrated clinically meaningful improvements in clinical remission in participants […]

AIM Congress Announces 15th Edition for 2026

DUBAI, United Arab Emirates, Oct. 06, 2025 (GLOBE NEWSWIRE) — The Organizing Committee of AIM Congress, the world's leading investment platform, has officially announced the launch of its 15th edition under the theme: Reshaping Global Prosperity: Unlocking New Investment Pathways Towards a Sustainable and Inclusive Future. AIM Congress will be held from 13 to 15

Niu Technologies Provides Third Quarter 2025 Sales Volume Update

Niu Technologies Provides Third Quarter 2025 Sales Volume Update GlobeNewswire October 06, 2025 BEIJING, Oct. 06, 2025 (GLOBE NEWSWIRE) — Niu Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world's leading provider of smart urban mobility solutions, today provided its sales volume results for the third quarter of 2025. 3Q 2025 3Q 2024 YTD 2025

AIM Congress Announces 15th Edition for 2026

AIM Congress Announces 15th Edition for 2026 GlobeNewswire October 06, 2025 DUBAI, United Arab Emirates, Oct. 06, 2025 (GLOBE NEWSWIRE) — The Organizing Committee of AIM Congress, the world's leading investment platform, has officially announced the launch of its 15th edition under the theme: Reshaping Global Prosperity: Unlocking New Investment Pathways Towards a Sustainable and

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies GlobeNewswire October 06, 2025 Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies 50 mg dose of once-daily obefazimod achieved clinically meaningful

Heineken(R) Is Calling People Back to the Office… But Not in the Way You Might Think

Heineken(R) Is Calling People Back to the Office… But Not in the Way You Might Think GlobeNewswire October 06, 2025 As debate rages on about going back to physical desks five days a week, Heineken(R) has cheekily renamed pubs across the UK to 'The Office' to celebrate one of the best parts of the working

Kyivstar Launches Large-Scale Telecom Network Modernization Project

Kyivstar Launches Large-Scale Telecom Network Modernization Project GlobeNewswire October 06, 2025 KYIV, Ukraine, Oct. 06, 2025 (GLOBE NEWSWIRE) — Kyivstar (Nasdaq: KYIV), Ukraine's leading digital operator, has initiated a large-scale network modernization project that will run throughout 2025-2026. The initiative aims to enhance service quality, expand 4G network capacity, and prepare infrastructure for fifth-generation (5G)

WirelessCar Strengthens Japanese Presence with Appointment of Satoru Abe as Country Manager

To advance partnerships with Japanese automakers and accelerate leadership in connected vehicle services, WirelessCar appoints Satoru Abe as Country Manager for Japan. WirelessCar, a global leader in connected vehicle services headquartered in Gothenburg, Sweden, announced today that Satoru Abe has been appointed Country Manager for WirelessCar Japan, based in Tokyo. Satoru Abe, WirelessCar Country Manager

Danaos Corporation Announces Senior Notes Offering

NOT FOR DISTRIBUTION TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT Danaos Corporation (the “Company”) (NYSE: DAC) announced today that it plans to commence an offering of up to $500 million of Senior Notes due 2032, subject to market conditions and other factors. The notes are

Freename Secures U.S. Patent for Milestone Protocol Bridging Web2 and Web3 Domains

ZURICH, Oct. 06, 2025 (GLOBE NEWSWIRE) — Freename, the leading Web3 domain registry and service, today announced the U.S. patent approval of its pioneering IT protocol designed to unify Web2 and Web3 domains under one secure, interoperable standard (Pub. No.: US 2025/0274430 A1). The protocol outlined in the patent provides a single point to coordinate,

Scroll to Top